dr. G.A. (Ardine (G.A.)) de Wit Associate Professor

Department of Public Health, Healthcare Innovation & Evaluation and Medical Humanities (PHM)
Julius Center Research Program Methodology

Contact

gwit@umcutrecht.nl

Research Programs

Circulatory Health

Biography

Ardine (G.A.) de Wit (1965) finished her studies of Health Sciences at Maastricht University (major: Health care policy and health economics) in 1989. Since graduation, she has been working as a researcher in the field of economic evaluation of health care and prevention, including research on health related quality of life measurement. She obtained a PhD of Erasmus University Rotterdam (thesis “Economic evaluation of end-stage renal disease treatment”, 2002). In May 2008, she was appointed Associated Professor (part-time) Health Technology Assessment at the Julius Center for Health Sciences and Primary Care, University Medical Center Utrecht. She heads the sub-department of Health Technology Assessment. Furthermore, since 1998 she holds an appointment as senior health economist at the National Institute of Public Health in the Netherlands (RIVM). Since 1993, she has been teaching economic evaluation methodology in several national and international courses. She is the course coordinator of the annual MSc specialty course on Methodology of Health economic evaluation.

Side Activities

Membership scientific advisory boards/committees;
- member (vice-chairman) of scientific advisory committee of the Netherlands Organisation for Health Research and Development – Prevention Programme
- member of scientific advisory committee of the Netherlands Organisation for Health Research and Development – Health Care Efficiency Research Programme
- member (vice-chairman) of scientific advisory committee of the Netherlands Organisation for Health Research and Development - Socio-economic differences in health
- member of scientific advisory committee of the National Health Care Institute
- board member of the Dutch Society for Technology Assessment in Health Care
- Senior health economist at the National Institute of Public Health and the Environment (RIVM)

Fellowship and Awards

Research Output (127)

Benefits and harms of high-dose haemodiafiltration versus high-flux haemodialysis:the comparison of high-dose haemodiafiltration with high-flux haemodialysis (CONVINCE) trial protocol

Blankestijn Peter J, Fischer Kathrin I, Barth Claudia, Cromm Krister, Canaud Bernard, Davenport Andrew, Grobbee Diederick E, Hegbrant Jörgen, Roes Kit C, Rose Matthias, Strippoli Giovanni Fm, Vernooij Robin Wm, Woodward Mark, de Wit G Ardine, Bots Michiel L 5 feb 2020, In: BMJ Open. 10 9 p.

Cost-effectiveness of the SLIMMER diabetes prevention intervention in Dutch primary health care:economic evaluation from a randomised controlled trial

Duijzer Geerke, Bukman Andrea J, Meints-Groenveld Aafke, Haveman-Nies Annemien, Jansen Sophia C, Heinrich Judith, Hiddink Gerrit J, Feskens Edith J M, de Wit G Ardine 11 nov 2019, In: BMC Health Services Research. 19

Dutch nOcturnal and hoME dialysis Study To Improve Clinical Outcomes (DOMESTICO):rationale and design

van Eck van der Sluijs A, Bonenkamp A A, Dekker F W, Abrahams A C, van Jaarsveld B C, , de Wit Ardine (G.A.) 18 sep 2019, In: BMC Nephrology. 20 8 p.

Cost-effectiveness of selective digestive decontamination (SDD) versus selective oropharyngeal decontamination (SOD) in intensive care units with low levels of antimicrobial resistance:an individual patient data meta-analysis

van Hout Denise, Plantinga Nienke L, Bruijning-Verhagen Patricia C, Oostdijk Evelien A N, de Smet Anne Marie G A, de Wit G Ardine, Bonten Marc J M, van Werkhoven Cornelis H 6 sep 2019, In: BMJ Open. 9

Healthcare costs of patients on different renal replacement modalities:Analysis of Dutch health insurance claims data

Mohnen Sigrid M, van Oosten Manon J M, Los Jeanine, Leegte Martijn J H, Jager Kitty J, Hemmelder Marc H, Logtenberg Susan J J, Stel Vianda S, Hakkaart-van Roijen Leona, de Wit G Ardine 15 aug 2019, In: PLoS ONE. 14

Designing Unforced Choice Experiments to Inform Health Care Decision Making:Implications of Using Opt-Out, Neither, or Status Quo Alternatives in Discrete Choice Experiments

Determann Domino, Gyrd-Hansen Dorte, de Wit G Ardine, de Bekker-Grob Esther W, Steyerberg Ewout W, Lambooij Mattijs S, Bjørnskov Pedersen Line 29 jul 2019, In: Medical Decision Making. 39 , p. 681-692 12 p.

Chronically ill patients' preferences for a financial incentive in a lifestyle intervention. Results of a discrete choice experiment

Molema Claudia, Veldwijk Jorien, Wendel-Vos Wanda, de Wit Ardine, van de Goor Ien, Schuit Jantine 25 jul 2019, In: PLoS ONE. 14

A social cost-benefit analysis of two One Health interventions to prevent toxoplasmosis

Suijkerbuijk Anita W M, Over Eelco A B, Opsteegh Marieke, Deng Huifang, Gils Paul F van, Bonačić Marinović Axel A, Lambooij Mattijs, Polder Johan J, Feenstra Talitha L, Giessen Joke W B van der, Wit G Ardine de, Mangen Marie-Josee J 1 mei 2019, In: PLoS ONE. 14

How psychological distance of a study sample in discrete choice experiments affects preference measurement:a colorectal cancer screening case study

Veldwijk Jorien, Groothuis-Oudshoorn Catharina G M, Kihlbom Ulrik, Langenskiöld Sophie, Dekker Evelien, Kallenberg Frank G J, de Wit G Ardine, Lambooij Mattijs S 12 feb 2019, In: Patient Preference and Adherence. 13 , p. 273-282 10 p.

Interpretation of CVD risk predictions in clinical practice:Mission impossible?

Lagerweij G. R., Moons K. G.M., De Wit G. A., Koffijberg H. 2019, In: PLoS ONE. 14

All Research Output (127)